Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.84, $0.06 better than the analyst estimate of $4.78. Revenue for the quarter came in at $531 million versus the consensus estimate of $538.07 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.